Literature DB >> 21679368

Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis.

H H Kwon1, I H Kwon, J W Choi, J I Youn.   

Abstract

BACKGROUND: Hyperuricaemia is a common finding in patients with psoriasis. However, previous studies have reported inconsistent results about the association between serum uric acid concentration (SUAC) and psoriasis severity. Recent studies have also reported that SUAC is associated with metabolic dysregulation. AIM: To assess any association between SUAC and clinical features of psoriasis, and to investigate the characteristics of patients with psoriasis with hyperuricaemia compared with similar patients with normouricaemia.
METHODS: Cross-sectional data from 198 Korean patients with psoriasis who visited our clinic were analysed. Association of SUAC with clinical features of psoriasis, body mass index (BMI) and various laboratory values was assessed in both genders separately.
RESULTS: The average uric acid concentration of patients with psoriasis was not significantly different from that of the healthy population, for both genders (P > 0.05). There was a positive correlation between SUAC and Psoriasis Area and Severity Index (PASI) and BMI in patients with psoriasis (P < 0.05). There was no association with age of disease onset, family history of psoriasis, or other laboratory values (P > 0.05), in either gender. Of the other factors of disease severity, the extent of body surface involvement was correlated with uric acid concentration (P < 0.05) although there was no significant relationship with activity of individual lesions (P > 0.05). Mean PASI and extent of psoriasis were increased in hyperuricaemic compared with normouricaemic patients (P < 0.05).
CONCLUSIONS: SUAC in patients with psoriasis is positively associated with PASI, extent of skin involvement and BMI for both genders independently. © The Author(s). CED
© 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679368     DOI: 10.1111/j.1365-2230.2010.03988.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  12 in total

1.  Psoriasis, psoriatic arthritis and risk of gout in US men and women.

Authors:  Joseph F Merola; Shaowei Wu; Jiali Han; Hyon K Choi; Abrar A Qureshi
Journal:  Ann Rheum Dis       Date:  2014-03-20       Impact factor: 19.103

2.  Chronic tophaceous gout in patients with psoriasis.

Authors:  Laís Cruz Lobato; Jéssica Castiel Coutinho; Maria Zeli Moreira Frota; Antonio Pedro Mendes Schettini; Mônica Santos
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

Review 3.  Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Xin Li; Xiao Miao; Hongshen Wang; Yifei Wang; Fulun Li; Qiong Yang; Rutao Cui; Bin Li
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.

Authors:  Panagiota Drivelegka; Valgerdur Sigurdardottir; Anna Svärd; Lennart T H Jacobsson; Mats Dehlin
Journal:  Arthritis Res Ther       Date:  2018-06-01       Impact factor: 5.156

5.  Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients.

Authors:  Seraj Ahmed Khan; Sudha Agrawal; Nirmal Baral; Madhab Lamsal
Journal:  Psoriasis (Auckl)       Date:  2018-09-04

6.  Evaluation of Serum Adenosine Deaminase and Inflammatory Markers in Psoriatic Patients.

Authors:  Yousry M Moustafa; Moustafa Ahmed Elsaied; Ehsan M Abd-Elaaty; Rasha A Elsayed
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

7.  Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients.

Authors:  S Gerdes; A Pinter; C Papavassilis; M Reinhardt
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-10-10       Impact factor: 6.166

8.  Updated Evidence of the Association Between Elevated Serum Uric Acid Level and Psoriasis.

Authors:  Ying Zhang; Liu Liu; Xiaoying Sun; Hongjin Li; Yifei Wang; Min Zhou; Liang Hua; Bin Li; Xin Li
Journal:  Front Med (Lausanne)       Date:  2021-06-29

9.  Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.

Authors:  Arzu Ataseven; Recep Kesli; Gulcan Saylam Kurtipek; Perihan Ozturk
Journal:  Dis Markers       Date:  2014-04-02       Impact factor: 3.434

10.  Paraoxonase-1 and other factors related to oxidative stress in psoriasis.

Authors:  Magdalena Oszukowska; Magdalena Kozłowska; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2020-03-09       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.